EDP-978
EDP 978-001
Phase 1 small_molecule active
Quick answer
EDP-978 for Chronic Inducible Urticaria is a Phase 1 program (small_molecule) at ENANTA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ENANTA PHARMACEUTICALS INC
- Indication
- Chronic Inducible Urticaria
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active